Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Too Early To Judge Tesla Motors Inc (TSLA) On China: Andrew Fung

Tesla Motors Inc (NASDAQ:TSLA) finally posted its fourth quarter earnings much to the disappointment of Wall Street as the company failed to meet revenue estimates with questions being asked about the company’s long-term prospects. During an interview on CNBC, CLSA vice president, Andrew Fung, reiterated an ‘Outperform’ rating on the stock with a $300 share price target. On belief that China sales will act as the key driver going forward.

Will Tesla Motors Inc (TSLA) CEO make Ford Motor Company (F) CEO Jealous with this Payout?

CEO, Elon Musk, has already stated that Tesla is revamping its approach on the sale of cars in China seen as a key marketplace that should rival the U.S. in terms of unit sales.  Chinese government push to control auto pollution is another aspect that should be of benefit to Tesla Motors Inc (NASDAQ:TSLA), on its push to sell more luxury cars in the country according to the analyst.

“Specifically in China we are encouraged by the aggressive action that the management is taking with changes in personnel and also taking over the process to install chargers and adding superchargers. In the end, it shows how much of a focus they have in that particular country; we are very optimistic on the outlook for China over the midterm,” said Mr. Fung.

Management problems especially with heads in China has been the biggest challenge facing Tesla Motors Inc (NASDAQ:TSLA) seen by the company appointing two heads in a span of 18 months. The appointments only go to suggest how difficult the marketplace is turning out to be.

Getting it right from the top in terms of leadership is essential if the company is to attain any breakthrough in terms sales in the country. Fung believes the aggressive sentiments that the company has shown in the recent times with regards to China should result in a rebound of sales in the months to come.

People in China have also been reluctant on making the switch to electric cars, a problem the company is addressing by opting to build more charging stations. Tesla Motors Inc (NASDAQ:TSLA) delivered a total of 9,834 vehicles in the fourth quarter below an initial target of 13,000 cars.

Judging Tesla Motors Inc (NASDAQ:TSLA) on its performance in China at the moment should be out of the picture according to the analyst as the company only launched last year.

“[…] we expect China to be probably as large as the U.S market over the midterm in 2020 or 2025, certainly they will need to scale back some of their investments and growth strategy if China doesn’t play out. I think it is too early to say that, that is the case they just entered the market in 2014 and then we will see how things progress from there,” said Mr. Fung.

Tesla releasing Model 3 that is to go on sale for $35,000 should act as a catalyst for increased unit volume sales, which should propel the stock to $300 a share, according to Fung

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks
Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!